Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthEquityFRA:2HE +3.01%95 Return-on-Tangible-Asset is 45.63% as of Apr. 2026, which is 278% above its 10-year median of 12.08. GuruFocus rates FRA:2HE with a GF Score™ of 95/100 and a GF Value™ of €87.77. The stock has 4 warning signs investors should review. Among 680 Healthcare Providers & Services companies, HealthEquity ranks better than 98.24% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. HealthEquity's annualizedNet Income for the quarter that ended in Apr. 2026 was €237 Mil. HealthEquity's average total tangible assets for the quarter that ended in Apr. 2026 was €520 Mil. Therefore, HealthEquity's annualized Return-on-Tangible-Asset for the quarter that ended in Apr. 2026 was 45.63%.
The historical rank and industry rank for HealthEquity's Return-on-Tangible-Asset or its related term are showing as below:
FRA:2HE'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -8.02 Med: 12.08 Max: 37.82
Current: 37.82
During the past 13 years, HealthEquity's highest Return-on-Tangible-Asset was 37.82%. The lowest was -8.02%. And the median was 12.08%.
FRA:2HE's Return-on-Tangible-Asset is ranked better than 98.24% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.465
vs FRA:2HE: 37.82
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
HealthEquity Return-on-Tangible-Asset Related Terms
HealthEquity Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for HealthEquity's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2HE vs TEM, TXG, HNGE: Return-on-Tangible-Asset Comparison
For the Health Information Services subindustry, HealthEquity's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthEquity Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where HealthEquity's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Apr. 2026) net income data.
What does a Return-on-Tangible-Asset of 45.63% mean?
HealthEquity (FRA:2HE) has a Return-on-Tangible-Asset of 45.63% as of Apr. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on HealthEquity and its competitors. This is 278% above median its historical median of 12.08. According to the industry distribution chart, HealthEquity ranks #12 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 1.8%.
Is HealthEquity's Return-on-Tangible-Asset too high?
HealthEquity's current Return-on-Tangible-Asset of 45.63% is 278% above median its 10-year median of 12.08. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.47. HealthEquity's value of 45.63% is 1751.1% above this industry median. Based on the distribution chart, HealthEquity ranks #12 out of 680 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, HealthEquity has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Return-on-Tangible-Asset compare to TEM and TXG?
According to the Healthcare Providers & Services industry distribution chart, HealthEquity ranks #12 out of 680 companies for Return-on-Tangible-Asset. This places HealthEquity in the top 2% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.47. HealthEquity's value of 45.63% is 1751.1% above this benchmark. While the company's 10-year median is 12.08 vs. the industry median of 2.47, HealthEquity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthEquity's current Return-on-Tangible-Asset of 45.63% is 1751.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on HealthEquity and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthEquity's current Return-on-Tangible-Asset is 45.63%, which is 278% above median its own 10-year median of 12.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Return-on-Tangible-Asset of 45.63%. The stock's GF Value™ is €87.77, compared to a current price of €85.50 — trading 2.6% below its estimated fair value. The current Return-on-Tangible-Asset is 45.63%, which is 278% above median its 10-year median of 12.08 and 1751.1% above the Healthcare Providers & Services industry median of 2.47. HealthEquity's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Return-on-Tangible-Asset is 45.63% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthEquity (FRA:2HE) Overvalued in 2026?
Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued.
The current stock price of €85.50 is trading 2.6% below its estimated GF Value™ of €87.77.
Key valuation signals for FRA:2HE:
Return-on-Tangible-Asset: 45.63% (278% above median its 10-year median of 12.08)
GF Value™: €87.77 vs. price of €85.50 (2.6% below fair value)
Industry Position: 1751.1% above the Healthcare Providers & Services median (#12 of 680)
No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
95GF Score
Get the complete analysis for FRA:2HE
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2HE has been successfully added to your 
